Neuropathology of preclinical and clinical late-onset Alzheimer's disease

被引:74
作者
Troncoso, JC
Cataldo, AM
Nixon, RA
Barnett, JL
Lee, MK
Checler, F
Fowler, DR
Smialek, JE
Crain, B
Martin, LJ
Kawas, CH
机构
[1] Johns Hopkins Univ, Sch Med, Neuropathol Lab, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Alzheimers Dis Res Ctr, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA
[5] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA
[6] McLean Hosp, Lab Mol Neurosci, Belmont, MA 02178 USA
[7] Harvard Univ, Sch Med, Dept Psychiat, Belmont, MA 02178 USA
[8] Harvard Univ, Sch Med, Dept Neuropathol, Belmont, MA 02178 USA
[9] Off Chief Med Examiner State Maryland, Baltimore, MD USA
[10] CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France
关键词
D O I
10.1002/ana.410430519
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We report on the neuropathological examinations of a 74-year-old woman with Alzheimer's disease (AD) and of her 47-year-old nondemented daughter. The brain of the mother showed fully developed pathological changes of AD. By contrast, the brain of the daughter revealed only perineuronal deposition of diffuse amyloid in cerebral cortex and striking abnormalities of the endosomal-lysosomal system, without neurofibrillary, glial, or microglial changes. These observations suggest that amyloid deposition and endosomal-lysosomal changes are early events in late-onset AD and that they may precede the onset of dementia by several decades.
引用
收藏
页码:673 / 676
页数:4
相关论文
共 20 条
[1]  
ARAKI W, 1994, NEUROSCI LETT, V171, P225
[2]   DEMONSTRATION OF AMYLOID BETA-PROTEIN SECRETION IN A MOUSE NEURONAL CELL-LINE [J].
ARAKI, W ;
KUNISHITA, T ;
TAKAHASHI, K ;
IKEDA, S ;
TABIRA, T .
NEUROSCIENCE LETTERS, 1994, 167 (1-2) :125-127
[3]   Characterization of new polyclonal antibodies specific for 40 and 42 amino acid long amyloid beta peptides: Their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic Alzheimer's disease and cerebral amyloid angiopathy cases [J].
Barelli, HL ;
Lebeau, A ;
Vizzavona, J ;
Delaere, P ;
Chevallier, N ;
Drouot, C ;
Marambaud, P ;
Ancolio, K ;
Buxbaum, JD ;
Khorkova, O ;
Heroux, J ;
Sahasrabudhe, S ;
Martinez, J ;
Warter, JM ;
Mohr, M ;
Checler, F .
MOLECULAR MEDICINE, 1997, 3 (10) :695-707
[4]   CLINICAL DEMENTIA RATING [J].
BERG, L .
BRITISH JOURNAL OF PSYCHIATRY, 1984, 145 (SEP) :339-339
[5]   GENERATION OF BETA-AMYLOID IN THE SECRETORY PATHWAY IN NEURONAL AND NONNEURONAL CELLS [J].
BUSCIGLIO, J ;
GABUZDA, DH ;
MATSUDAIRA, P ;
YANKNER, BA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (05) :2092-2096
[6]  
Cataldo AM, 1997, J NEUROSCI, V17, P6142
[7]  
Cataldo AM, 1996, J NEUROSCI, V16, P186
[8]   GENE-EXPRESSION AND CELLULAR CONTENT OF CATHEPSIN-D IN ALZHEIMERS-DISEASE BRAIN - EVIDENCE FOR EARLY UP-REGULATION OF THE ENDOSOMAL LYSOSOMAL SYSTEM [J].
CATALDO, AM ;
BARNETT, JL ;
BERMAN, SA ;
LI, JH ;
QUARLESS, S ;
BURSZTAJN, S ;
LIPPA, C ;
NIXON, RA .
NEURON, 1995, 14 (03) :671-680
[9]   MINI-MENTAL STATE - PRACTICAL METHOD FOR GRADING COGNITIVE STATE OF PATIENTS FOR CLINICIAN [J].
FOLSTEIN, MF ;
FOLSTEIN, SE ;
MCHUGH, PR .
JOURNAL OF PSYCHIATRIC RESEARCH, 1975, 12 (03) :189-198
[10]  
GRIFFIN WST, 1995, J NEUROPATH EXP NEUR, V54, P276